ABOUT US
ILC Dover, an Ingersoll Rand business, is a global leader in engineered flexible containment solutions for the pharmaceutical and biopharmaceutical industries. With more than 25 years of expertise in single-use powder and liquid handling systems, ILC Dover enables manufacturers to safely process highly potent active pharmaceutical ingredients (HPAPIs), protect operators, and ensure product integrity across the drug development and manufacturing lifecycle from early-stage R&D through commercial production.
Our portfolio of single-use containment technologies, including flexible isolators, closed transfer systems, and powder handling solutions, is designed to meet the evolving demands of modern pharmaceutical manufacturing. By containing processes at the source, ILC Dover solutions help reduce cross-contamination risk, minimize cleaning validation requirements, and support compliance with cGMP, FDA, and global regulatory standards.
Serving advanced therapeutic applications such as biologics, cell and gene therapy, antibody-drug conjugates (ADCs), and GLP-1 manufacturing, ILC Dover combines deep material science expertise with innovative engineering to deliver scalable, high-performance containment systems. Our solutions are proven to improve operational efficiency, accelerate time to market, and maintain the highest standards of safety and quality in aseptic and high-potency environments.
With global manufacturing capabilities and ISO-certified facilities, including ISO Class 7 cleanroom production environments, ILC Dover delivers regulatory-compliant, high-quality single-use systems designed for consistency, reliability, and performance at scale.
CONTACT INFORMATION
ILC Dover, An Ingersoll Rand Business
One Moonwalker Road
Frederica, DE 19946
UNITED STATES
Phone: 1-302-335-3911 ext. 1506
Contact: ilcdover.com/en/company/locations/
FEATURED ARTICLES
-
Eliminate particulate contamination and product degradation in downstream bioprocessing. Learn how frictionless, levitating impeller technology ensures low-shear mixing and high yields.
-
Optimize containment in oral GLP-1 solid dose manufacturing. Learn how closed single-use containment and flexible isolators secure blending, spray drying, and tableting workflows.
-
Enhance containment and process reliability in oral GLP-1 synthesis. Discover how integrated single-use assemblies and automated fluidics safeguard chemical purity during scale-up.
-
Scale your GLP-1 peptide synthesis efficiently. Discover how automated solid-phase workflows and single-use fluidics maximize crude purity while reducing total solvent consumption.
-
Managing cytotoxic ADC payloads in shared containment facilities creates mounting compliance, safety, and operational costs that single-use isolator technology is designed to address.
-
Containing highly potent APIs across a full operational lifecycle requires a structured approach that addresses hazard scoring, quality by design, performance testing, and safe enclosure disposal.
-
Outdated containment infrastructure in OSD facilities creates costly compliance gaps and operational bottlenecks. Flexible single-use isolator systems offer a faster, more adaptable path forward.
-
This clear hood for biopharmaceutical facility employees improved safety and performance while promising economic savings.
-
Find a reliable source of cGMP raw materials, diverse packaging options, and solutions for material storage that can minimize the total cost of ownership and maximize productivity.
-
Improve your fluid transfer by exploring customer-specified assemblies designed for the storage and transfer of sterile fluids in biopharmaceutical manufacturing with an optimized quality system.
-
Technology has evolved to make high-containment systems financially reasonable. Explore how single-use containment technology impacts capital spending and operating expenses.
-
This webinar covers a well-designed, single-use flexible enclosure system that delivers equivalent if not better containment performance than a hard-shell isolator, at a fraction of the cost.
-
Flexible film isolation systems previously tended to be a composite of stainless-steel chambers and airflow modules. Here, we investigate the development of a fully disposable aseptic isolation system.
-
Here, we explore the advantages and disadvantages of lyophilization and share examples of lyophilizer solutions and containment designs.
-
Explore applications where flexible isolators have been used, including the containment assessments to confirm performance and ergonomic benefits, and a specific case of using a negative pressure isolator.
-
Understand the challenges of small molecule manufacturing and HPAPI containment as well as the benefits of using secure single-use technology to expand your capabilities and meet process demands.
-
Learn about best in class solutions to streamline the transfer process, resulting in more accurate and faster production and improved batch cycle times.
NEWS
- ILC Dover Expands Life Sciences Presence With Water For Injection (WFI) And Custom Chemical Solutions
- ILC Dover Unveils Sentinel XT™ Horizon For Innovative Respiratory Protection With Unmatched Comfort & Safety
- Ingersoll Rand Closes On ILC Dover and Announces Acquisition Of Three Additional Companies
- ILC Dover Secures North Carolina Facility To Expand Dry Repack Capabilities And Build Out cGMP Raw Materials Portfolio
- ILC Dover Announces New Multi-Compendial Water For Injection Solutions For Biopharma And Cell & Gene Therapy Market
- Solving API Manufacturing Challenges With Flexible Containment Webinar Announced for June 21
- ILC Dover Plans To Build New Manufacturing Facility In Poland To Meet Biopharma Industry Needs